article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes.

article thumbnail

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. The post DarshanTalks: Sales & Marketing Oversight </br>– April 21, 2021 appeared first on Pharma Marketing Network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Keep Your 2021 Sales Pipeline Full Using the Selling Lessons of 2020

Integrity Solutions

But before you barrel ahead into 2021 and look for signs of returning to the “good old days,” sales leaders and their teams have a lot to learn from 2020. In fact, your success in 2021 depends on it. Research from HubSpot shows that 68% of sales leaders plan to implement a hybrid or fully remote sales model in 2021.

article thumbnail

Guest Episode – DarshanTalks: Marketing and Evolving Patient Centricity – February 1, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021. Check out DarshanTalks for more of his insightful podcasts.

article thumbnail

Guest Episode – DarshanTalks: Marketing and Evolving Patient Centricity – February 1, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021.

article thumbnail

Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout

MedCity News

Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.

article thumbnail

Aurobindo Pharma-Openings for M.Pharmacy Freshers -Apply Now

Pharma Pathway

Pharmacy- Pharmaceutics as Specialization (2021 & 2022 Pass outs only). Pharmacy- Pharmaceutics Analysis as Specialization (2021 & 2022 Pass outs only). Formulations R&D (OSD): M. Formulations Analytical R&D (Derma): M.

Pharma 75